SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-048848
Filing Date
2014-08-12
Accepted
2014-08-12 15:03:30
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v385647_10q.htm 10-Q 383675
2 EXHIBIT 31.1 v385647_ex31-1.htm EX-31.1 11856
3 EXHIBIT 31.2 v385647_ex31-2.htm EX-31.2 11344
4 EXHIBIT 32.1 v385647_ex32-1.htm EX-32.1 5091
5 EXHIBIT 32.2 v385647_ex32-2.htm EX-32.2 5702
  Complete submission text file 0001144204-14-048848.txt   3035881

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20140630.xml EX-101.INS 359034
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20140630.xsd EX-101.SCH 34207
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20140630_cal.xml EX-101.CAL 25376
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20140630_def.xml EX-101.DEF 163482
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20140630_lab.xml EX-101.LAB 246235
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20140630_pre.xml EX-101.PRE 192200
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 141033679
SIC: 2834 Pharmaceutical Preparations